Recarey-Rama, S.; Gómez-Trigo, J.; Gil-Rodriguez, A.; Dominguez, E.; Sánchez-Martínez, I.; Riveiro-Recimil, Á.; Barral-Raña, A.; de Leon, J.; Rodriguez-Viyuela, A.; Arrojo, M.;
et al. The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review. Pharmaceuticals 2025, 18, 623.
https://doi.org/10.3390/ph18050623
AMA Style
Recarey-Rama S, Gómez-Trigo J, Gil-Rodriguez A, Dominguez E, Sánchez-Martínez I, Riveiro-Recimil Á, Barral-Raña A, de Leon J, Rodriguez-Viyuela A, Arrojo M,
et al. The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review. Pharmaceuticals. 2025; 18(5):623.
https://doi.org/10.3390/ph18050623
Chicago/Turabian Style
Recarey-Rama, Sheila, Jesús Gómez-Trigo, Almudena Gil-Rodriguez, Eduardo Dominguez, Inés Sánchez-Martínez, Ángela Riveiro-Recimil, Alba Barral-Raña, Jose de Leon, Ana Rodriguez-Viyuela, Manuel Arrojo,
and et al. 2025. "The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review" Pharmaceuticals 18, no. 5: 623.
https://doi.org/10.3390/ph18050623
APA Style
Recarey-Rama, S., Gómez-Trigo, J., Gil-Rodriguez, A., Dominguez, E., Sánchez-Martínez, I., Riveiro-Recimil, Á., Barral-Raña, A., de Leon, J., Rodriguez-Viyuela, A., Arrojo, M., Carracedo, A., & Maroñas, O.
(2025). The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review. Pharmaceuticals, 18(5), 623.
https://doi.org/10.3390/ph18050623